Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Study of HIF-1α in Cirrhosis by Fecal Microbiota Transplantation

NCT04591522 is registered in ClinicalTrials.gov with First Affiliated Hospital of Wenzhou Medical University as lead sponsor.

NCT NCT04591522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04591522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Study of HIF-1α in Cirrhosis by Fecal Microbiota Transplantation
Lead sponsor
First Affiliated Hospital of Wenzhou Medical University
Phase
Not applicable
Overall status
Unknown status
Start date
October 15, 2020
Completion date
June 30, 2022
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, liver